0/100 · Low Risk
No Adverse Events Reported for Butalbital
Last updated: 2026-05-12
BUTALBITAL is a medication tracked in the FDA Adverse Event Reporting System (FAERS). Based on analysis of FDA adverse event reports, BUTALBITAL has a safety score of 0 out of 100. This lower score reflects a significant number of adverse event reports, suggesting that patients should discuss potential risks carefully with their healthcare provider. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for BUTALBITAL.
Butalbital has a safety concern score of 0 out of 100, placing it in the low concern category based on analysis of FDA adverse event data. The FDA has received approximately N/A adverse event reports for this medication.
No serious or non-serious adverse events reported for Butalbital.
The drug has not shown any safety concerns based on the available data. No new safety signals have been identified from the reported data.
Patients taking Butalbital should monitor for the commonly reported side effects and contact their healthcare provider if they experience any unusual symptoms. This analysis is based on voluntary FDA adverse event reports and should not replace professional medical advice.
Butalbital received a safety concern score of 0/100 (low concern). The score accounts for N/A total adverse event reports and 0 distinct reaction types. This relatively low score suggests a favorable safety profile in reported data.
Demographic data for adverse event reporters is limited for this medication.
If you are taking Butalbital, here are important things to know. Continue to follow your healthcare provider's instructions for using Butalbital. Report any unusual symptoms to your healthcare provider promptly. If you experience a serious adverse reaction, seek emergency medical attention immediately or call 911. You can report side effects to the FDA's MedWatch program at 1-800-FDA-1088.
The FDA has received approximately N/A adverse event reports associated with Butalbital. These reports come from healthcare professionals, consumers, and manufacturers through the FDA Adverse Event Reporting System (FAERS). Note that the number of reports does not directly indicate the frequency of side effects, as adverse events are voluntarily reported and may be underrepresented.
You can report adverse events from Butalbital to the FDA through their MedWatch program at www.fda.gov/medwatch, by calling 1-800-FDA-1088, or by completing Form FDA 3500. Healthcare professionals, consumers, and manufacturers can all submit reports. Reporting helps the FDA monitor drug safety after approval.
Butalbital has a safety concern score of 0 out of 100 (low concern). This score is calculated from the ratio of serious to non-serious adverse events, the diversity of reported reactions, and the overall volume of reports relative to usage. No serious or non-serious adverse events reported for Butalbital.
Key safety signals identified in Butalbital's adverse event data include: No serious adverse events reported.. No non-serious adverse events reported.. These signals are derived from patterns in FDA reports and should be discussed with a healthcare provider for personalized assessment.
Continue to follow your healthcare provider's instructions for using Butalbital. Report any unusual symptoms to your healthcare provider promptly.
Butalbital has N/A adverse event reports on file with the FDA. The drug has not shown any safety concerns based on the available data. The volume of reports for Butalbital reflects both the drug's usage level and the vigilance of the reporting community.